Authors: HART W HOLWERDA NJ

Citation: W. Hart et Nj. Holwerda, BARNIDIPINE, A NOVEL CALCIUM-ANTAGONIST FOR ONCE-DAILY TREATMENT OF HYPERTENSION - A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY, Cardiovascular drugs and therapy, 11(5), 1997, pp. 637-643

Authors: HEYNDRICKX G RENARD M BEIL S DOERING W KAUDER E KLEPZIG H SCHACHERER C HAASS M KRUGER C LIMBOURG P LIOMIN E MAISCH B SCHARTL M SIMON H BERNINK PJLM FELS PW DOHMEN HJM DUNSELMAN PHJM BASELIER MRP HOLWERDA NJ LAARMAN GJ LEENDERS CM VANLEEUWEN K MICHELS HR VANDERENT M REMME WJ WITHAGEN AJAM GUNDERSEN T OTTERSTAD JE FROLAND G PEDERSEN TR FERREIRA JRG DESA EP SEABRAGOMES R GIL V ABDON NJ JONSSON J LUBSEN J

Citation: G. Heyndrickx et al., EFFECT OF PIMOBENDAN ON EXERCISE CAPACITY IN PATIENTS WITH HEART-FAILURE - MAIN RESULTS FROM THE PIMOBENDAN IN CONGESTIVE-HEART-FAILURE (PICO) TRIAL, HEART, 76(3), 1996, pp. 223-231

Authors: HOLWERDA NJ FOGARI R ANGELI P PORCELLATI C HERENG C ODDOUSTOCK P HEATH R BODIN F

Citation: Nj. Holwerda et al., VALSARTAN, A NEW ANGIOTENSIN-II ANTAGONIST FOR THE TREATMENT OF ESSENTIAL-HYPERTENSION - EFFICACY AND SAFETY COMPARED WITH PLACEBO AND ENALAPRIL, Journal of hypertension, 14(9), 1996, pp. 1147-1151